Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Product

Dolutegravir/Abacavir/Lamivudine FDC

Aliases
Dolutegravir/abacavir/lamivudine FDC

1 clinical trial

3 indications

Indication
Infection
Indication
HIV
Indication
HIV Infections
Clinical trial
A Phase IIIb, Randomized, Open-label Study of the Safety and Efficacy of Dolutegravir/Abacavir/Lamivudine Once Daily Compared to Atazanavir and Ritonavir Plus Tenofovir/Emtricitabine Once Daily in HIV-1 Infected Antiretroviral Therapy Naïve Women
Status: Completed, Estimated PCD: 2015-09-22